3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
102
Active not recruiting
42
Completed
36
Terminated
14
Not yet recruiting
11
Withdrawn
5
Enrolling by invitation
3
Suspended
1
Sponsor Class
INDUSTRY
2
OTHER
1
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Genitourinary
3
Thoracic
2
Other solid neoplasm
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
CNS
1
Breast
1
Conditions
Neoplasms
51
Breast Neoplasms
40
Colorectal Neoplasms
26
Prostatic Neoplasms
22
Lung Neoplasms
18
Carcinoma, Non-Small-Cell Lung
15
Carcinoma, Hepatocellular
15
Stomach Neoplasms
14
Hematologic Neoplasms
10
Brain Neoplasms
10
Pancreatic Neoplasms
9
Colonic Neoplasms
9
Urinary Bladder Neoplasms
8
Lymphoma, Follicular
8
Head and Neck Neoplasms
8
Uterine Cervical Neoplasms
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Ovarian Neoplasms
7
Melanoma
7
Liver Neoplasms
7
Leukemia, Myeloid, Acute
7
Disease
7
Anxiety Disorders
7
Myasthenia Gravis
6
Multiple Myeloma
6
Squamous Cell Carcinoma of Head and Neck
5
Sarcoma
5
Rectal Neoplasms
5
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Kidney Neoplasms
×
1 year
×
Clear all
NCT06885424
2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
400 enrolled
NCT07307157
2025-12-29
COSMO
Harvard Medical School (HMS and HSDM)
Enrolling by invitation
30 enrolled
NCT06945640
2025-09-16
HTK_002
Hutom Corp
Phase NA
Enrolling by invitation
80 enrolled